English | Español
Patient Daily | Apr 24, 2023

Baycrest’s Goal Management Training now offered through TELUS Health’s AbilitiCBT platform
Patient Daily | Apr 24, 2023

Syft, a GHX Company, Achieves Imprivata Single Sign-On Certification
Patient Daily | Apr 24, 2023

Global Healthcare Exchange Announces Plan to Acquire Prodigo Solutions
Patient Daily | Apr 24, 2023

2022 GHX Millennium Club Honorees Are Transforming the Healthcare Supply Chain
Patient Daily | Apr 24, 2023

Tempus Announces Seven Abstracts Accepted For Presentation at the American Association for Cancer Research Annual Meeting 2023
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community
Patient Daily | Apr 24, 2023

Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Regulatory
Patient Daily | May 12, 2025

Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'